D. Dvornik

发表

Comparative Bioavailability of Propranolol: Twice‐Daily Versus Four Times‐Daily Administration

D. Dvornik, M. Kraml, J. Dubuc, 1981, Journal of clinical pharmacology.

Aldose Reductase Inhibition: An Approach to the Prevention of Diabetic Complications

D. Dvornik, 1987 .

Evaluation of the lipid-lowering activity of AY-25,712 in rats.

M. Cayen, D. Dvornik, J. Dubuc, 1982, Atherosclerosis.

Effect of AY-25,712 and Other Lipid-Lowering Agents on Liver Catalase and Liver Carnitine Acetyltransferase in Rats 1

M. Cayen, D. Dvornik, J. Dubuc, 1983, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Disposition and biotransformation of 14C-etodolac in man.

M. Cayen, D. Dvornik, J. Dubuc, 1986, Xenobiotica; the fate of foreign compounds in biological systems.

Effect of tolrestat on red blood cell sorbitol levels in patients with diabetes

P. Raskin, J. Rosenstock, D. Dvornik, 1985, Clinical pharmacology and therapeutics.

Prevention of Basement Membrane Thickening in Retinal Capillaries by a Novel Inhibitor of Aldose Reductase, Tolrestat

D. Dvornik, Y. Akagi, J. Kinoshita, 1986, Diabetes.

Tolrestat pharmacokinetics in rat peripheral nerve.

D. Dvornik, M. Kraml, J. Millen, 1994, Journal of diabetes and its complications.

Combined effects of clofibrate and diosgenin on cholesterol metabolism in rats.

M. Cayen, D. Dvornik, 1978, Atherosclerosis.

Dynamics of propranolol dosing schedules

D. Dvornik, J. Mullane, D. Weidler, 1983, Clinical pharmacology and therapeutics.

Propranolol dosage, plasma concentration, and beta blockade

D. Dvornik, J. Mullane, J. Kaufman, 1982, Clinical pharmacology and therapeutics.

Clofibrate and clofibric acid: comparison of the metabolic disposition in rats and dogs.

M. Cayen, D. Dvornik, E. Ferdinandi, 1977, The Journal of pharmacology and experimental therapeutics.

Aldose reductase inhibitors as pathobiochemical probes.

D. Dvornik, 1992, Journal of diabetes and its complications.

Resistance of the diabetic rat nerve to ischemic inactivation.

D. Dvornik, J. Jaramillo, N. Simard-Duquesne, 1985, Canadian journal of physiology and pharmacology.

Pharmacokinetics and hypolipidemic activity of clofibrate-nicotinic acid combinations in rats.

M. Cayen, D. Dvornik, J. Dubuc, 1979, Biochemical pharmacology.

AGENTS AFFECTING LIPID METABOLISM. XV. BIOCHEMICAL STUDIES WITH THE CHOLESTEROL BIOSYNTHESIS INHIBITOR AY-9944 IN YOUNG AND MATURE RATS.

D. Dvornik, M. Givner, 1965, Biochemical pharmacology.

Aminoguanidine does not inhibit aldose reductase activity in galactose-fed rats.

D. Dvornik, T. Hohman, M. Basso, 1996, Journal of diabetes and its complications.

Effect of diosgenin on lipid metabolism in rats.

M. Cayen, D. Dvornik, 1979, Journal of lipid research.

Biopharmaceutical characteristics of a new propranolol/hydrochlorothiazide tablet combination.

D. Dvornik, M. Kraml, J. Dubuc, 1982, Biopharmaceutics & drug disposition.

Prevention of Cataract Development in Severely Galactosemic Rats by the Aldose Reductase Inhibitor, Tolrestat

D. Dvornik, R. González, E. Greselin, 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Effect of AY-25,712 on fatty acid metabolism in rats.

M. Cayen, D. Dvornik, J. Dubuc, 1982, Atherosclerosis.

The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats.

D. Dvornik, J. Dubuc, E. Greselin, 1985, Metabolism: clinical and experimental.

Prevention of Neural Myoinositol Depletion in Diabetic Rats by Aldose Reductase Inhibition with Tolrestat 1

D. Dvornik, C. Kemper, Christopher A. Kemper, 1986, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Studies on the disposition of diosgenin in rats, dogs, monkeys and man.

M. Cayen, D. Dvornik, E. Ferdinandi, 1979, Atherosclerosis.

Theoretical mechanism for the gastrointestinal safety of etodolac: Selective sparing of cytoprotective prostaglandins

D. Dvornik, D. Lee, D. Lee, 1989, Clinical Rheumatology.

Etodolac: effect on prostaglandin concentrations in gastric mucosa of rats.

D. Dvornik, D. Lee, 1985, Life sciences.

The metabolic disposition of acifran, a new antihyperlipidemic agent, in rats and dogs.

M. Cayen, D. Dvornik, M. Kraml, 1986, Xenobiotica; the fate of foreign compounds in biological systems.

Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat.

J. Sredy, D. Dvornik, M. McCaleb, 1988, The Journal of diabetic complications.

Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys.

M. Cayen, D. Dvornik, M. Kraml, 1985, Drug metabolism and disposition: the biological fate of chemicals.

N-((5-(TRIFLUOROMETHYL)-6-METHOXY-1-NAPHTHALENYL)THIOXOMETHYL)-N-METHYLGLYCINE (TOLRESTAT), A POTENT, ORALLY ACTIVE ALDOSE REDUCTASE INHIBITOR

A. Treasurywala, D. Dvornik, S. Fung, 1984 .

Galactitol accumulation and irreversible lens opacities in galactosemic rats.

D. Dvornik, N. Simard-Duquesne, 1973, Investigative ophthalmology.

Inhibition of the conversion of 7-dehydrocholesterol to cholesterol by AY-9944.

D. Dvornik, M. Kraml, J. Bagli, 1964, Biochemical and biophysical research communications.

A Novel Mode of Inhibition of Cholesterol Biosynthesis

D. Dvornik, M. Kraml, J. Dubuc, 1963 .

Agents affecting lipid metabolism. 28. A 7-dehydrocholesterol delta-7-reductase inhibitor (AY-9944) as tool in studies of delta-7-sterol metabolism.

D. Dvornik, M. Kraml, J. Bagli, 1966, Biochemistry.

Agents affecting lipid metabolism. XXVI. Specificity of some inhibitors of the late stages of cholesterol biosynthesis

D. Dvornik, M. Kraml, J. Dubuc, 2006, Lipids.

N-[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]- N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor.

A. Treasurywala, D. Dvornik, S. Fung, 1984, Journal of medicinal chemistry.

Polyol Accumulation in Galactosemic and Diabetic Rats: Control by an Aldose Reductase Inhibitor

D. Dvornik, K. Gabbay, J. Kinoshita, 1973, Science.

Modification of the spectrophotofluorometric determination of griseofulvin.

D. Dvornik, M. Kraml, J. Dubuc, 1965, Journal of pharmaceutical sciences.

Gastrointestinal absorption of griseofulvin. Levels in the serum of human patients on prolonged B.I.D. administration of micronized and common griseofulvin.

D. Dvornik, M. Kraml, J. Dubuc, 1963, Archives of dermatology.

The effect of an aldose reductase inhibitor on the galactose-exposed rabbit lens.

D. Dvornik, M. Kraml, K. Gabbay, 1968, Biochimica et biophysica acta.

A gas-liquid chromatographic determination of p-chlorophenoxyisobutyric acid and its comparison to an ultra violet method.

D. Dvornik, M. Kraml, W. Robinson, 1975, Clinical biochemistry.

An Inhibitor of Cholesterol Biosynthesis

D. Dvornik, M. Kraml, J. Dubuc, 1964, Nature.

Chapter 23. Fate and Distribution of Drugs

D. Dvornik, D. A. Buyske, 1966 .

Accumulation of 24-Dehydrocholesterol in Rats Treated with 22,25-Diazacholestanol

D. Dvornik, M. Kraml, 1963 .

A gas-liquid chromatographic method for the determination of butriptyline in serum.

D. Dvornik, M. Kraml, H. Bruderlein, 1977, Clinical biochemistry.

Agents affecting lipid metabolism. XXXVII. Separation of rat serum lipoproteins with dextran sulfate.

D. Dvornik, P. Hill, 1969, Canadian journal of biochemistry.

Adrenergic beta receptors and plasma free fatty acids.

D. Dvornik, M. Kraml, T. Zsotér, 1966, The Journal of pharmacology and experimental therapeutics.

The effect of some inhibitors of the postganglionic sympathetic mechanism on monoamine oxidase

D. Dvornik, M. Kraml, J. Dubuc, 1963 .

Metabolism of the anticonvulsant 10,11-dihydro-5H-dibenzo(a,d)cycloheptene-5-carboxamide. I. Metabolic fate of (14C)cyheptamide in animals and man.

D. Dvornik, M. Kraml, K. Sestanj, 1971, Biochemical pharmacology.

Agents affecting lipid metabolism. XL. Effect of ethyl chlorophenoxyisobutyrate on liver lipids and serum lipoproteins in rats.

D. Dvornik, P. Hill, 1971, Canadian journal of biochemistry.

Agents affecting lipid metabolism. XXXIX. Effect of combined administration of ethyl chlorophenoxyisobutyrate and cholestyramine on cholesterol biosynthesis in the rat.

M. Cayen, D. Dvornik, 1970, Canadian journal of biochemistry.

An Inhibitor of Adrenal Steroid 11β-Hydroxylase

D. Dvornik, M. Kraml, M. Givner, 1964, Nature.

Inhibition of testosterone biosynthesis by medrogestone

D. Dvornik, M. Givner, 1972, Experientia.

Effect of Primidone (Mysoline) on Tissular Levels of Griseofulvin in the Rat

D. Dvornik, M. Kraml, A. Marton, 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Effect of long-term administration of AY-9944, an inhibitor of 7-dehydrocholesterol delta 7-reductase, on serum and tissue lipids in the rat.

D. Dvornik, P. Hill, 1968, Journal of lipid research.

Bioavailability studies with etodolac in dogs and man.

D. Dvornik, M. Kraml, J. Mullane, 1984, Biopharmaceutics & drug disposition.

Effect of tibric acid on hepatic cholesterol synthesis in rats

M. Cayen, D. Dvornik, J. Dubuc, 1977, Lipids.

Hypolipidemic activity of 2,8-dibenzyl-cyclooctanone in rats.

M. Cayen, D. Dvornik, J. Dubuc, 1976, Biochemical pharmacology.

Endogenous Formation of Δ5,7,24-Cholestatrien-3βol

D. Dvornik, M. Kraml, J. Bagli, 1964 .

Inderal® LA: comparison of the profiles of plasma drug concentration/time curves produced in man by propranolol hydrochloride long-acting (80 and 160 MG) and atenolol (50 and 100 MG)

D. Dvornik, J. Mullane, S. Ryder, 1984 .